Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
Dermata Therapeutics (DRMA) Stock Price & Analysis
53 Followers
DRMA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.23 - $3.68
Previous Close$0.32
Volume37.78K
Average Volume (3M)160.02K
Market Cap
$2.14M
Enterprise Value$2.14M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)>-0.1
Beta1.44
Next Earnings
May 13, 2024EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.98
Shares Outstanding6,660,840
10 Day Avg. Volume317,828
30 Day Avg. Volume160,020
Standard Deviation0.23
R-Squared0.04
Alpha-0.13
Financial Highlights & Ratios
Price to Book (P/B)0.34
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
Dermata Therapeutics News
PremiumCompany Announcements
Dermata Therapeutics: Unveiling Recent Financial Performance
DRMA FAQ
What was Dermata Therapeutics’s price range in the past 12 months?
Dermata Therapeutics lowest stock price was $0.23 and its highest was $3.68 in the past 12 months.
What is Dermata Therapeutics’s market cap?
Currently, no data Available
When is Dermata Therapeutics’s upcoming earnings report date?
Dermata Therapeutics’s upcoming earnings report date is May 13, 2024 which is in 18 days.
How were Dermata Therapeutics’s earnings last quarter?
Dermata Therapeutics released its earnings results on Mar 21, 2024. The company reported -$0.45 earnings per share for the quarter, beating the consensus estimate of -$0.78 by $0.33.
Is Dermata Therapeutics overvalued?
According to Wall Street analysts Dermata Therapeutics’s price is currently Overvalued.
Does Dermata Therapeutics pay dividends?
Dermata Therapeutics does not currently pay dividends.
What is Dermata Therapeutics’s EPS estimate?
Dermata Therapeutics’s EPS estimate is -$0.36.
How many shares outstanding does Dermata Therapeutics have?
Dermata Therapeutics has 6,660,840 shares outstanding.
What happened to Dermata Therapeutics’s price movement after its last earnings report?
Dermata Therapeutics reported an EPS of -$0.45 in its last earnings report, beating expectations of -$0.78. Following the earnings report the stock price went up 5%.
Which hedge fund is a major shareholder of Dermata Therapeutics?
Currently, no hedge funds are holding shares in DRMA
---
Dermata Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 14.1%
Last 30 Days ▼ 14.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.46%
12-Months-Change
Fundamentals
Return on Equity
-125.96%
Trailing 12-Months
Asset Growth
14.89%
Trailing 12-Months
Company Description
Dermata Therapeutics
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
---
DRMA Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Corbus Pharmaceuticals
―
Citius Pharmaceuticals
―
Eagle Pharmaceuticals
―
Heron Therapeutics
―
Best Analysts Covering DRMA
1 Year
1 Year Success Rate
0/13 ratings generated profit
1 Year Average Return
-76.94%
reiterated a buy rating 30 days ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -76.94% per trade.
---